NCT00314054View on ClinicalTrials.gov

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Hepatitis CHepatic Insufficiency
Interventions
DRUG

HCV-796

HCV-796 1000mg single dose

Trial Locations (3)

32608

Gainesville

32809

Orlando

55114

Saint Paul

Sponsors

Collaborators (1)

ViroPharma
All Listed Sponsors
collaborator

ViroPharma

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00314054 - Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults | Biotech Hunter | Biotech Hunter